PRESS RELEASE
News
-
-
PRESS RELEASE
CLS Holdings USA Inc. ("CLSH") Announces Repayment of $1,526,250 in Principal and Interest Debenture Obligations Along with the Repurchase of 13,274,780 Shares of the Company
CLS Holdings USA, Inc. announces debt retirement and share repurchase, strengthening shareholder value. Very low stock price-per-share transaction accretive to shareholders. CEO Andrew Glashow comments on the significant step forward -
PRESS RELEASE
Metallic Minerals Announces Inaugural 18 Million Silver Equivalent Ounce NI 43-101 Mineral Resource Estimate for the Keno Silver Project in Yukon, Canada
Metallic Minerals Corp. announces the first NI-43-101 mineral resource estimate for the Keno Silver project in Canada's Yukon Territory, with significant resource expansion anticipated through further drilling campaigns -
PRESS RELEASE
Fellaz to Launch Fellaz Plus, a Web3 Fan Engagement Solution as It Expands Its Partnership With Major Global Content IP and Music Powerhouses
Singapore-based Fellaz announces the launch of Fellaz Plus, a Web3 social platform revolutionizing fan engagement with DAO structure and incentives. Features include chat, live-streaming, and diverse entertainment partnerships -
PRESS RELEASE
Original-Research: Schloss Wachenheim (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research reaffirms Buy rating for Schloss Wachenheim AG with a target price of €22.00 following Q2 23/24 results. Despite challenges, SWA maintains sales growth outlook at 5% for the full year -
-
-
-
-
PRESS RELEASE
FSD Pharma Signs Agreement With Ingenu CRO to Conduct a Clinical Trial To Determine the Safety and Efficacy Effects of its Proprietary Blend Beverage unbuzzd(TM)
FSD Pharma Inc. announced an agreement for a clinical trial to test unbuzzd™ effects on faster alcohol metabolism. The trial aims to confirm the supplement's potential benefits in sobering up from alcohol intoxication
